Insider · CIK 0001612842

Wagner Paul A.

Reports to the SEC for 2 companies · DALLAS, TX

sec.gov

Transactions

Companies

Filings

CIK

0001612842

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-27	FBRXForte Biosciences, Inc.U Disposition from Tender	Director, SEE REMARKS	UDisposition from Tender	−85.5K sh	—	—	0
2026-08-27	FBRXForte Biosciences, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director, SEE REMARKS	DDisposition to Issuer	−16.9K sh	—	—	0
2026-08-27	FBRXForte Biosciences, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director, SEE REMARKS	DDisposition to Issuer	−5,400 sh	—	—	0
2026-08-27	FBRXForte Biosciences, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director, SEE REMARKS	DDisposition to Issuer	−12K sh	—	—	0
2026-08-27	FBRXForte Biosciences, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director, SEE REMARKS	DDisposition to Issuer	−44K sh	—	—	0
2026-08-27	FBRXForte Biosciences, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director, SEE REMARKS	DDisposition to Issuer	−920K sh	—	—	0
2026-08-27	FBRXForte Biosciences, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director, SEE REMARKS	DDisposition to Issuer	−270K sh	—	—	0
2026-08-27	FBRXForte Biosciences, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director, SEE REMARKS	DDisposition to Issuer	−500K sh	—	—	0
2026-08-27	FBRXForte Biosciences, Inc. · Restricted Stock UnitsD Disposition to Issuer	Director, SEE REMARKS	DDisposition to Issuer	−2,500 sh	—	—	0
2026-08-27	FBRXForte Biosciences, Inc. · Restricted Stock UnitsD Disposition to Issuer	Director, SEE REMARKS	DDisposition to Issuer	−180K sh	—	—	0
2026-08-27	FBRXForte Biosciences, Inc. · Restricted Stock UnitsD Disposition to Issuer	Director, SEE REMARKS	DDisposition to Issuer	−3,511 sh	—	—	0
2026-07-01	FBRXForte Biosciences, Inc.M Exercise/Conversion	Director, SEE REMARKS	MExercise/Conversion	+1,250 sh	—	—	85,580
2026-07-01	FBRXForte Biosciences, Inc.F Tax Payment	Director, SEE REMARKS	FTax Payment	−98 sh	$21.32	−$2,089.36	85,482
2026-07-01	FBRXForte Biosciences, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, SEE REMARKS	MExercise/Conversion	−1,250 sh	—	—	2,500
2026-06-16	FBRXForte Biosciences, Inc. · Stock Option (right to buy)A Award	Director, SEE REMARKS	AAward	+500K sh	—	—	500,000
2026-04-01	FBRXForte Biosciences, Inc.M Exercise/Conversion	Director, SEE REMARKS	MExercise/Conversion	+1,250 sh	—	—	84,428
2026-04-01	FBRXForte Biosciences, Inc.F Tax Payment	Director, SEE REMARKS	FTax Payment	−98 sh	$24.86	−$2,436.28	84,330
2026-04-01	FBRXForte Biosciences, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, SEE REMARKS	MExercise/Conversion	−1,250 sh	—	—	3,750
2026-01-12	FBRXForte Biosciences, Inc. · Stock Option (right to buy)A Award	Director, SEE REMARKS	AAward	+270K sh	—	—	270,000
2026-01-12	FBRXForte Biosciences, Inc. · Restricted Stock UnitsA Award	Director, SEE REMARKS	AAward	+180K sh	—	—	180,000
2026-01-01	FBRXForte Biosciences, Inc.M Exercise/Conversion	Director, SEE REMARKS	MExercise/Conversion	+1,250 sh	—	—	83,342
2026-01-01	FBRXForte Biosciences, Inc.F Tax Payment	Director, SEE REMARKS	FTax Payment	−164 sh	$27.27	−$4,472.28	83,178
2026-01-01	FBRXForte Biosciences, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, SEE REMARKS	MExercise/Conversion	−1,250 sh	—	—	5,000
2025-10-01	FBRXForte Biosciences, Inc.M Exercise/Conversion	Director, SEE REMARKS	MExercise/Conversion	+1,250 sh	—	—	82,190
2025-10-01	FBRXForte Biosciences, Inc.F Tax Payment	Director, SEE REMARKS	FTax Payment	−98 sh	$14.52	−$1,422.96	82,092
2025-10-01	FBRXForte Biosciences, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, SEE REMARKS	MExercise/Conversion	−1,250 sh	—	—	6,250
2025-07-01	FBRXForte Biosciences, Inc.M Exercise/Conversion	Director, SEE REMARKS	MExercise/Conversion	+1,250 sh	—	—	81,038
2025-07-01	FBRXForte Biosciences, Inc.F Tax Payment	Director, SEE REMARKS	FTax Payment	−98 sh	$12.44	−$1,219.12	80,940
2025-07-01	FBRXForte Biosciences, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, SEE REMARKS	MExercise/Conversion	−1,250 sh	—	—	7,500
2025-04-01	FBRXForte Biosciences, Inc.M Exercise/Conversion	Director, SEE REMARKS	MExercise/Conversion	+1,250 sh	—	—	79,806
2025-04-01	FBRXForte Biosciences, Inc.F Tax Payment	Director, SEE REMARKS	FTax Payment	−18 sh	$7.43	−$133.74	79,788
2025-04-01	FBRXForte Biosciences, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, SEE REMARKS	MExercise/Conversion	−1,250 sh	—	—	8,750
2025-03-20	FBRXForte Biosciences, Inc. · Stock Option (right to buy)A Award	Director, SEE REMARKS	AAward	+920K sh	—	—	920,000
2025-01-01	FBRXForte Biosciences, Inc.M Exercise/Conversion	Director, SEE REMARKS	MExercise/Conversion	+1,250 sh	—	—	78,720
2025-01-01	FBRXForte Biosciences, Inc.F Tax Payment	Director, SEE REMARKS	FTax Payment	−164 sh	$22.71	−$3,724.44	78,556
2025-01-01	FBRXForte Biosciences, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, SEE REMARKS	MExercise/Conversion	−1,250 sh	—	—	10,000
2024-10-01	FBRXForte Biosciences, Inc.M Exercise/Conversion	Director, SEE REMARKS	MExercise/Conversion	+1,250 sh	—	—	77,568
2024-10-01	FBRXForte Biosciences, Inc.F Tax Payment	Director, SEE REMARKS	FTax Payment	−98 sh	$5.16	−$505.68	77,470
2024-10-01	FBRXForte Biosciences, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, SEE REMARKS	MExercise/Conversion	−1,250 sh	—	—	11,250
2024-07-01	FBRXForte Biosciences, Inc.M Exercise/Conversion	Director, SEE REMARKS	MExercise/Conversion	+31.3K sh	—	—	1,910,424
2024-07-01	FBRXForte Biosciences, Inc.F Tax Payment	Director, SEE REMARKS	FTax Payment	−2,453 sh	$0.55	−$1,339.338	1,907,971
2024-07-01	FBRXForte Biosciences, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, SEE REMARKS	MExercise/Conversion	−31.3K sh	—	—	312,500
2024-04-01	FBRXForte Biosciences, Inc.M Exercise/Conversion	Director, SEE REMARKS	MExercise/Conversion	+31.3K sh	—	—	1,881,627
2024-04-01	FBRXForte Biosciences, Inc.F Tax Payment	Director, SEE REMARKS	FTax Payment	−2,453 sh	$0.71	−$1,735.498	1,879,174
2024-04-01	FBRXForte Biosciences, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, SEE REMARKS	MExercise/Conversion	−31.3K sh	—	—	343,750
2024-03-21	FBRXForte Biosciences, Inc. · Stock Option (right to buy)A Award	Director, SEE REMARKS	AAward	+1.1M sh	—	—	1,100,000
2024-01-01	FBRXForte Biosciences, Inc.M Exercise/Conversion	Director, SEE REMARKS	MExercise/Conversion	+31.3K sh	—	—	1,854,486
2024-01-01	FBRXForte Biosciences, Inc.F Tax Payment	Director, SEE REMARKS	FTax Payment	−4,109 sh	$0.82	−$3,376.365	1,850,377
2024-01-01	FBRXForte Biosciences, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, SEE REMARKS	MExercise/Conversion	−31.3K sh	—	—	375,000
2023-12-18	FBRXForte Biosciences, Inc.P Purchase	Director, SEE REMARKS	PPurchase	+10K sh	$0.75	+$7,525	1,823,236

Recent filings

Accepted (ET)
Aug 274
Wagner Paul A.0001612842-26-000011
SEC(opens sec.gov)
Jul 64
Wagner Paul A.0001612842-26-000010
SEC(opens sec.gov)
Jun 174
Wagner Paul A.0001612842-26-000008
SEC(opens sec.gov)
Apr 34
Wagner Paul A.0001612842-26-000006
SEC(opens sec.gov)
Jan 134
Wagner Paul A.0001612842-26-000004
SEC(opens sec.gov)

Companies

Address

C/O FORTE BIOSCIENCES, INC. 3060 PEGASUS PARK DR., BLDG 6

DALLAS, TX, 75247